Decreased expression of integrins by hematopoietic cells in patients with rheumatoid arthritis and anemia: Relationship with bone marrow cytokine levels

Journal of Investigational Allergology and Clinical Immunology

Volumn 18, Issue 1, 2008, Pages 17-21

  Jaworski, Janusz ^a   Maslinski, W ^a   Pazdur, J ^a   Sliwinska Stanczyk, P ^a   Kaminska Tchorzewska, E ^a   Jung, L ^a   Lacki, J K ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

Anemia of chronic disease; Bone marrow; Integrins; Interleukin 3; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN; INTEGRIN; INTERLEUKIN 3; TUMOR NECROSIS FACTOR; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

ANEMIA; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE SEDIMENTATION RATE; HEMATOPOIETIC CELL; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

ANEMIA; ARTHRITIS, RHEUMATOID; BONE MARROW; CHRONIC DISEASE; CYTOKINES; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHA5BETA1; INTERLEUKIN-3; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40349098216     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pierer M, Wagner U, Hantzschel H, Gay RA, Gay S. Pathogenesis of inflammatory rheumatic disease of the joints-current research findings. In: Laufer S, Gay S, Brune K, editors. Inflammation and rheumatic diseases. Stuttgart: Georg Thieme Verlag; 2003. p. 1-10
2. Skobin V, Jelkmann W, Morschakova E, Pavlov AD, Schlenke P. Tumor necrosis factor-alfa and TNF-beta inhibit clonogenicity of mobilized human hematopoietic progenitors. J Interferon Cytokine Res. 2000;20:507-10.
3. Cartwright GE, Lee GR. The anemia of chronic disorders. Br J Haematol. 1971; 21:,617-22
4. Segal R, Baumoehl Y, Elkayam O, Levartovsky D, Litinsky I, Paran D, Wigler I, Habot B, Leibovitz A, Sela BA, Caspi D. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int. 2004;24:14-9.
5. Vreugdenhil G, Lowenberg B, Swaak AJG. Tumor necrosis factor alfa is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis. Eur J Clin Investig.1992;22:488-93.
6. Vreugdenhil G, Lowenberg B, Swaak AJG, van Eijk HG. Raised serum interleukin-6 levels and effects of IL-6 and anti-IL- 6 on in vitro erythropoiesis. Rheumatol Int. 1990;10:127-30.
7. Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Anemia of chronic disease in RA is associated with increased apoptosis of bone marrow erythroid cells following anti tumor necrosis factor antibody therapy. Blood. 2002;100:474-82.
8. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 1996;352:428-41.
9. Davies D, Charles PJ, Potter A, Feldmann M, Maini RN, Elliott MJ. Anemia of chronic disease in rheumatoid arthritis: In vivo effects of tumour necrosis factor alpha blockade. Br J Rheumatol.1997;36:950-6.
10. Hamamura K, Matsuda H, Takeuchi Y, Habu S, Yagita H, Okumura K. A critical role of VLA-4 in erythropoiesis in vitro. Blood. 1996;87:2513-7.
11. Asaumi N, Omoto E, Mahmut N, Katayama Y, Takeda K, Shinagawa K, Harada M. Very late antigen-5 leukocyte function-associated antigen-1 are critical for early stage hematopoietic progenitor cell homing. Ann Hematol. 2001;80:387-92.
12. Means RT, Dessypris EN, Krantz SB. Inhibition of human erytroid CFU by IL-1 is mediated by gamma interferon. J Cellular Physiol. 1992;150:59-64.
13. Yamaguchi M, Ikeuchi K, Hirayama F, Sato N, Mogi Y, Ohkawara J. Different adhesive characteristics and VLA-4 expression of CD34+ progenitors in G0/G1 versus S + G2/M phases of the cell cycle. Blood.1998;92:842-8.
14. Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24
15. Ezawa K, Yamamura M, Matsui H, Ota Z, Makino H. Comparative analysis of CD45RA- and CD45RO positive CD4+ T cells in peripheral blood, synovial fluid and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Act Med Okayama. 1997;51:25-31.
16. Lansdorp PM, Sutherland HJ, Eaves CJ. Selective expression of CD45RO isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J Exp Med. 1990;172:363-6.
17. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205-13.
18. Lacki JK, Wassmuth R, Korczowska K, Mackiewicz SH, Muller W. The presence of HLA-DR B1 shared motif does not influence cyclophosphamide and methotrexate cytotoxicity in RA patients. J Investig Allergol Clin Immunol. 2000;10:235-41.
19. Kaijzel EL, van Krugten MV, Brinkman BM, Huizinga TW, van der Straaten T, Hazes JM, Ziegler-Heitbrock HW, Nedospasov SA, Breedveld FC, Verweij CL. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med.1998;4:724-33.
20. Brinkman BM, Huizinga TW, Kurban SS, van der Velde EA, Schreuder GM, Hazes JM, Breedveld FC, Verweij CL. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol. 1997;36:516-21.
21. Gracie JA, Koyama N, Murdoch J, Field M, McGarry F, Crilly A, Schobel A, Madhok R, Pons-Kuhnemann J, McInnes IB, Moller B. Disease association of two distinct interleukin-18 promotor polymorphisms in Caucasian rheumatoid arthritis patients. Genes Immun. 2005;6:211-6.
22. Lacki JK, Moser R, Korczowska I, Mackiewicz S, Muller W. TNF-alpha gene polymorphism does not affect clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int. 2000;19:137-40.
23. Kang CP, Lee KW, Yoo DH, Kang C, Bae SC. The influence of a polymorphism at position -857 of the TNF alpha gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology. 2005;44:705-7.
24. Kim SY, Han SW, Kim GW, Lee JM, Kang YM. TGF-beta1 polymorphism determines the progression of joint damage in rheumatoid arthritis. Scand J Rheumatol. 2004;33:389-94.